Predicting ovarian cancer type and surgery results
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at women with advanced ovarian cancer to see if certain factors can predict the type of cancer and how well surgery will work. It may help doctors plan the best treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have advanced ovarian cancer (stage IIIB to IVB).
- You are healthy enough for surgery to remove the cancer.
- You are having a diagnostic laparoscopy as part of your treatment plan.
- You agree to let the researchers use your data.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks surgeons to review video from a patient's diagnostic laparoscopy and predict how far the cancer has spread. The goal is to see how good surgeons are at estimating the extent of ovarian cancer in the abdomen.
This study looks back at records of people with advanced ovarian cancer to see if changing the order of their treatments might help them live longer. It focuses on those who had a certain type of surgery at a French hospital between 2010 and 2022.
This study uses lab testing to create a “map” of ovarian cancer cells one cell at a time, to better understand the disease. It likely helps researchers learn which cell types are involved, using samples collected around your surgery.
This trial checks whether having surgery to remove as much tumor as possible, followed by ongoing targeted treatment, helps people with advanced ovarian (and related) cancers live longer and/or control cancer better. It specifically uses tumor-testing results to match patients and then continues treatment after surgery.
This study looks at how well a minimally invasive surgery (laparoscopic debulking) can remove tumor in people with advanced epithelial ovarian cancer. It may help doctors compare whether this approach is safe and effective for patients who need either upfront surgery or surgery after chemotherapy.
This study looks at whether the timing of surgery after chemotherapy can be personalized for advanced ovarian cancer. It uses a blood test (CA125) to help decide the best time for surgery, aiming to improve outcomes.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.